Notice ID: df66178661af4c48a8bf6878d1a03596Award NoticeAwarded
Brain Tissue
Awarded on August 11, 2022. Full description on SAM.gov.
Awarded tounder 75N95022P00486 (source: SAM.gov award notice)• $50.4K
Overview
- Posted
- August 11, 2022
- Notice type
- Award Notice
- NAICS
- 621991: Blood and Organ Banks
- Agency
- Department of Health and Human Services
Notice details
- Place of performance
- 4000, MD
- Last updated
- Dec 4, 2025
- Award date
- Aug 11, 2022
- Award amount (SAM.gov award notice)
- $50.4K
Identifiers
- Solicitation number
- 75N95022Q00337
- Notice ID
- df66178661af4c48a8bf6878d1a03596
- Award number (PIID)
- 75N95022P00486
Description
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95022Q00337 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Aging (NIA), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Banner Health for Postmortem human brain specimens from Alzheimer’s disease, Mild Cognitive Impairment, and Controls. This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2022-06, with effective date May 26, 2022. (iv) The associated NAICS code 621991 and the small business size standard is $35 million. No set-aside restriction is applicable. (v) This requirement is for the following items: Brain Samples. (vi) A major objective of the National Institute on Aging (NIA) is to identify and characterize molecular derangements that occur early in the Alzheimer’s disease (AD) process, both in brain and in blood. The Lipid Peroxidation Unit places a particular emphasis on identifying derangments in lipid metabolism-related pathways and markers (such as ApoE). To achieve these objectives, NIA requires rapidly autopsied specimens from key regions that are involved in the earliest stages of AD (pons, entorhinal cortex, hippocampus) from a cohort that spans the full spectrum of AD. Most of NIA’s lipid metabolism related assays and IHC cytoarchitectural markers require formalin-fixed paraffin embedded (FFPE) specimens. Others require frozen specimens. Therefore, NIA requires both types of specimens, preferably from the same cohort of autopsied participants. Please see the attached Purchase Description for detailed requirements. (vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated delivery date is 45 days after receipt of order (ARO). Delivery will be f.o.b. destination. The place of delivery and acceptance will be: 251 Bayview Blvd Baltimore, MD 21224 (viii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Oct 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.212-1, Instructions to Offerors-Commercial Items (Nov 2021) FAR 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021) FAR 52.222-22, Previous Contracts and Compliance Reports (FEB 1999) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2021). Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74, Electronic and Information Technology Accessibility (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (May 2022) Invoicing Instructions With IPP 4-21-22 (ix) The provision at FAR clause 52.212-2, Evaluation-Commercial Items (Nov 2021), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical capability of the item offered to meet the Government requirement; (ii) past performance [see FAR 13.106-2(b)(3)]; (iii) price. Technical and past performance, when combined, are significantly more important than price. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items (Nov 2021), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. (xi) The clause at FAR 52.212-4, Contract Terms and Conditions-Commercial Items (Nov 2021), applies to this acquisition. Addendum to this FAR clause applies to this acquisition and is attached. (xii) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xiii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xiv) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. Such factors may include: past performance, special features required for effective program performance, trade-in considerations, probable life of the item selected as compared with that of a comparable item, warranty considerations, maintenance availability, and environmental and energy efficiency considerations. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by 12:00 PM Eastern Time, on Friday, August 5th, 2022, and reference Solicitation Number 75N95022Q00337. Responses must be submitted electronically to rashiid.cummins@nih.gov Fax responses will not be accepted.
Award Overview
Award Number
75N95022P00486
Award Amount (SAM.gov award notice)
$50.4K
Award Date
Aug 11, 2022
Awardee
Awardee UEI
SB35ENJFKK14
Original Solicitation
Notice ID: df66178661af4c48a8bf6878d1a03596
Posted Date: Aug 11, 2022
Original Response Deadline: Not specified
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95022Q00337- Market Research
- Combined Synopsis
- Awarded
This opportunity has been awarded.
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a Firm-Fixed price, single-award IDIQ to Carter Bloodcare, for procurement of the following Blood and Blood Products (“X” represents Ordering Periods 1-5): Item # Description Est Annual Needs Unit X001 *Red Cells, Leukocyte reduced 4056 Unit X002 Platelets, Pheresis, Leukocyte reduced 416 Unit X003 Fresh frozen plasma, OR Plasma frozen <24 hours 350 Unit X004 Cryoprecipitate, frozen pooled from 5 donors 150 Unit X005 Platelet-pheresis, HLA matched 5 Unit X006 Deglycerolyzed Red cells 5 Unit X007 Freezing of Patient RBC 5 Ea X008 Deglycerolization of frozen RBC 5 Ea X009 Irradiation Fee 1000 Ea X010 Class 1 HLA Type 1 Ea X011 HLA Typing; A, B, C, single antigen 1 Ea X012 HLA-A,B, Molecular; Request Coding 1 Ea X013 HLA Computer match fee 10 Ea X014 ABID; PLT Immunoglobulin Assay XM 5 Ea X015 ABID; PLT Immunoglobulin Assay PLA1 1 Ea X016 ABID; Platelet Antibody 3 Ea X017 Washing (red blood cells) 3 Ea X018 Antigen Screen, Tier 1 antigen (C, c, E, or K) 30 Ea X019 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) 50 Ea X020 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) 50 Ea X021 ABO/Rh type 10 Ea X022 Blood Typing-ABO/Rh Discrepancy 2 Ea X023 Antibody Screen, RBC, each Serum Technique 10 Ea X024 Cold Agglutinin, Screen 1 Ea X025 AHG Test; Direct, each antiserum 5 Ea X026 ABID, RBC Antobodies, ea panel 10 Ea X027 Antibody Elution (RBC), each 6 Ea X028 Pretreat RBC with Enzymes, each 3 Ea X029 Pretreat Serum with Absorption x1 2 Ea X030 Pretreat Serum with Absorption x2 2 Ea X031 Pretreat Serum with Absorption x3 2 Ea X032 Drug Studies Request Coding 1 Ea X033 Lectin Panel (Polyagglutination) 1 Ea X034 CMV Negative 3 Ea X035 HgB S Negative 5 Ea X036 Frozen Blood Storage (up to 90 days) 3 Ea X037 Imported Rare Unit Fee 5 Ea X038 Molecular RBC Genotype 20 Ea X039 RHD Molecular Testing 5 Ea X040 RhCE Molecular Testing 5 Ea X041 Molecular Sequencing 1 Ea X042 STAT Reference Testing Fee 30 Ea X043 Sample Pick-Up, Time Sensitive 10 Ea X044 Sample Pick Up – Zone 2 30 Ea X045 Therapeutic Phlebotomy Donation 100 Ea The Dallas Veteran Affairs Health Care Center has a requirement for the supply and delivery of blood and blood products supporting the North Texas Veterans Health Care System (VANTHCS). Contractor will furnish all personnel, labor, transportation, equipment, materials and supplies necessary to provide Human Blood and Blood Products and guidance in Clinical Pathology Procedures as specified herein for eligible VA beneficiaries of the North Texas Veterans Health Care System, VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, by email, to the point of contact and referencing the notice ID 36C25727Q0055, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 21 days from the publication of this notice, a contract/order will be issued to Carter Bloodcare, without any further notice. The proposed contract action is for supplies for which the Government intends to negotiate with only one source. The statutory authority permitting other than full and open competition is 41 U.S.C. § 3304(a)(1), as implemented by FAR 6.103-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The proposed sole source procurement will be made by a pricing agreement with Carter Bloodcare. See attached document: Statement of Work - Blood and Blood Products for North Texas VA. | 57% | Special Notice | 11/13/2026 |
Special Notice Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Network Contracting Office 17, intends to award a Firm-Fixed price, single-award IDIQ to South Texas Blood and Tissue Center, for procurement of the following Blood and Blood Products ( X represents Ordering Periods 1-5): The Audie L. Murphy Veteran Affairs Health Care Center has a requirement for the supply and delivery of blood and blood products supporting the South Texas Veterans Health Care System (STVHCS). Contractor will furnish all personnel, labor, transportation, equipment, materials and supplies necessary to provide Human Blood and Blood Products and guidance in Clinical Pathology Procedures as specified herein for eligible VA beneficiaries of the South Texas Veterans Health Care System, Audie L. Murphy Division located at 7400 Merton Minter Blvd., San Antonio, TX 78229-4404. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, by email, to the point of contact and referencing the notice ID 36C25727Q0049, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 21 days from the publication of this notice, a contract/order will be issued to the South Texas Blood and Tissue Center, without any further notice. The proposed contract action is for supplies for which the Government intends to negotiate with only one source. The statutory authority permitting other than full and open competition is 41 U.S.C. § 3304(a)(1), as implemented by FAR 6.103-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The proposed sole source procurement will be made by a pricing agreement with South Texas Blood and Tissue Center. | 57% | Special Notice | 11/05/2026 |
47% | Awarded | Open | |
Blood products and Immunohematology for the Fayetteville VAMC | 44% | Solicitation | 09/25/2026 |
This pre-solicitation notice is not a request for formal quotes. The Department of Veterans Affairs, VISN 06, Network Contract Office (NCO) 06, Fayetteville VAMC, located at 2300 Ramsey Street, Fayetteville, NC 28301, intends to solicit quotes in the Open-Market for Blood Components and Immunohematology Lab Testing. The Department of Veterans Affairs anticipates issuing an open and continuous solicitation for this requirement on or about September 18th, 2026. The solicitation will provide instructions to contractors about the proposal submission process. Quotes will be accepted for an seven (7) day period commencing with the solicitation issuance date. Interested contractors will be responsible for downloading copies of the solicitation (and any subsequent amendments) from that website, and no hard copies will be made available. In accordance with FAR 52.204-7, System for Award Management, prospective contractors must be registered in the System for Award Management (SAM). Contractors may obtain SAM information at https://www.sam.gov. The vendor must be registered in the System for Award Management database to be eligible for an award. Registration is free, and potential offerors are encouraged to visit the SAM website, as no contract can be awarded to any offeror not registered in SAM. The VA will only consider proposals from contractors registered as mentioned above and not on the Excluded Parties List. NAICS Code is 621991, with a Small Business Size Standard of $40,000,000. The solicitation will be issued for the market. One award is expected to be made. All responsible sources may submit quotes to be considered by the Department of Veterans Affairs. The service is to be performed at: Department of Veterans Affairs Veterans Affairs Medical Center 2300 Ramsey Street Fayetteville, NC 28301-3856 Service: 36C246Q0726 Blood Components and Immunohematology Lab Testing In response, please include the following: Company Name Address Point of contact (POC) with phone number Indicate FSS/GSA contract number or Open Market, if applicable SAM Unique Entity Identification (UEI) number Tax ID number Socio-Economic Company SIZE (for example large, small, SDVOSB, VOSB, WOSB, etc.) Proof of verification as an SDVOSB/VOSB (if applicable) Questions concerning this announcement should be directed to Jonathan Lamb at Jonathan.Lamb@va.gov; please ensure that the subject line includes: 36C246Q0726 Blood Components and Immunohematology Lab Testing. Telephone requests for information or questions will NOT be accepted. | 44% | Pre-Solicitation | 09/18/2026 |
Additional Details
Solicitation Number
75N95022Q00337
Archive Date
Aug 26, 2022
Office Address
Bethesda, MD, 20892